logo
Deel admits it instructed 'discreet' surveillance on spy case man

Deel admits it instructed 'discreet' surveillance on spy case man

BreakingNews.ie25-06-2025
One of the companies in the international HR firms' "spy" dispute instructed that "discreet" surveillance be carried out on the Irish payroll compliance manager at the centre of High Court proceedings over the affair, a High Court judge has been told.
US headquartered Deel Inc, which allegedly recruited Dublin man Keith O'Brien to pass on trade secrets to it from his employer Rippling, also headquartered in the US, did not instruct that there be covert or intimidatory surveillance on Mr O'Brien, Mr Justice Brian Cregan was told.
Advertisement
Last Friday, Mr O'Brien, of Balrothery in north Dublin, was granted a one side only represented injunction preventing "persons unknown", who were seen driving two different cars in the vicinity of Mr O'Brien's home and workplace, from harassing or intimidating him by following, photographing and recording him or members of his family.
They were also restrained from attending within one kilometre of those places.
The case was against persons unknown because his lawyers did not, at that stage, know the identities of the owners/drivers of the vehicles.
The court was also told by Imogen McGrath SC, for Mr O'Brien, that it was believed the people involved were working for Deel and the conduct was designed to intimidate him because he had agreed to cooperate with Rippling in a separate case it is bringing over the spy affair against Deel and Mr O'Brien.
Advertisement
The court heard however that, in response to requests to desist, Deel's solicitors Hayes LLP had written to say their client had "no knowledge" of surveillance by any persons in the vehicles identified.
On Wednesday, when the case returned to the High Court, Ms McGrath said there had been dramatic developments over the previous 24 hours.
The identities associated with the two cars had been provided and the owner/driver of one car allegedly seen in one incident, a couple who attended court, were not involved in any surveillance and the case against them was being discontinued, counsel said.
The driver of the second vehicle, which was involved in five other alleged incidents of following and surveilling, had also come forward.
Advertisement
John O'Regan BL, for the second driver, asked the judge that his client's name be anonymised until he is able to make a formal application in this respect.
Counsel said the application will be in accordance with case precedent or statute law because his client has significant health issues and operates "in the sphere of surveillance", and revealing his identity could put his safety at risk and damage his business.
Counsel also asked the case be put back as his client, while refuting Mr O'Brien's claims, wanted to come to a practical agreement in relation to the court orders.
Mr Justice Cregan said he was prepared to hear the application for anonymisation of the defendant but was reluctant to make an order in relation to that at this stage.
Advertisement
The court heard that while Deel was not a defendant in Mr O'Brien's action, which includes a claim for damages, the judge had directed that their lawyers attend court on Wednesday to say why they should or should not be a party.
Paul Gardiner SC, for Deel, told the judge his client had instructed that "discreet surveillance" be carried out on Mr O'Brien, but there was no question that it should be covert and used to intimidate or harass him.
"My client (Deel) engaged with Person B (to carry out surveillance) and unknown to us, they engaged Person A and Deel was not involved in instructing anyone to carry out intimidation, and we refute that", he said.
The judge said given Deel's solicitors' response to requests to desist from Mr O'Brien's lawyers of having "no knowledge" of those involved in following him, it "could be interpreted as being economical with the verité (truth)".
Advertisement
Mr Gardiner replied his side only ascertained the actual position over the weekend. He also said his client was agreeable to not surveilling Mr O'Brien any further, and if he wished that Deel should be a defendant, he should serve papers to that effect.
Ms McGrath, for Mr O'Brien, said they would have to consider that as they would need to see what instructions, including text messages, Deel gave to Person B to carry out the surveillance.
The judge continued the injunctions and adjourned the matter for a week.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Marks and Spencer bring back online shopping in Ireland
Marks and Spencer bring back online shopping in Ireland

BreakingNews.ie

time13 minutes ago

  • BreakingNews.ie

Marks and Spencer bring back online shopping in Ireland

M&S has brought back online shopping in Ireland. Its customers can now shop fashion, home, and beauty ranges on and through the retailer's app. Advertisement All ranges can be shopped for online for free home delivery on orders above €50, or the M&S free click and collect service can be used to pick up orders from any M&S store across Ireland. Online orders can also now be returned to Irish M&S stores. The retailer thanked its customers for their support: "We are incredibly grateful."

Irish leaders welcome clarity on EU-US trade deal and pharma tariffs set at 15%
Irish leaders welcome clarity on EU-US trade deal and pharma tariffs set at 15%

The Independent

time16 minutes ago

  • The Independent

Irish leaders welcome clarity on EU-US trade deal and pharma tariffs set at 15%

Ireland's premier and deputy premier have welcomed clarity on the EU-US trade deal, which sets a maximum tariff rate of 15% for the pharmaceutical sector. Taoiseach Micheal Martin said it was a 'significant win' for the EU and highlighted the arrangements for the pharmaceutical and aviation sectors. The statement said that as of September 1, the US will apply a maximum tariff rate of 15% on 'generic pharmaceuticals and their ingredients and chemical precursors'. Simon Harris, Ireland's deputy premier and Minister for Foreign Affairs and Trade, welcomed the clarity the statement offered on the EU-US trade agreement announced on July 27. 'We welcome clarity that the deal includes a single, all-inclusive 15% tariff on EU goods,' Mr Harris said. 'We also now have assurance that this rate will extend to pharmaceuticals and semiconductors. 'This provides an important shield to Irish exporters that could have been subject to much larger tariffs pending the outcomes of Section 232 US investigations into these sectors.' There is also a 'zero-for-zero' tariff rate carve outs for aircraft and aircraft parts, with further carve outs to be determined for certain products in generic pharmaceuticals and chemicals. Mr Harris said this offered a 'first step' to a more 'comprehensive and formal agreement with the US in the future'. 'Our intention now is to see what other carve outs can be made in areas of interest for Irish exporters.' Irish premier Micheal Martin said the statement brought 'greater clarity and certainty' to what the agreement between the EU and the US will mean in practice. 'This is especially important for enterprises that either import from or export to the US. 'Given the scale of the pharmaceutical and semiconductor sectors in Ireland, it is important that the Joint Statement confirms that 15% is a ceiling that will apply to EU exports in these areas in all circumstances, including when the current US Section 232 investigations are concluded. 'While I have been clear all along that I do not support tariffs, this is a significant win for the EU. 'Given the significance of the airline sector to Ireland, a specific carve-out for aircraft and aircraft parts is also welcome. 'There are areas where further work remains to be done, including a potential carve-out for med-tech products and spirits. 'I hope this will be advanced as quickly as possible. We will continue to advocate for these sectors given their significant importance to our domestic economy.'

Irish leaders welcome clarity on EU-US trade deal and pharma tariffs set at 15 per cent
Irish leaders welcome clarity on EU-US trade deal and pharma tariffs set at 15 per cent

BreakingNews.ie

time17 minutes ago

  • BreakingNews.ie

Irish leaders welcome clarity on EU-US trade deal and pharma tariffs set at 15 per cent

The Taoiseach and Tánaiste have welcomed clarity on the EU-US trade deal, which sets a maximum tariff rate of 15 per cent for the pharmaceutical sector. Taoiseach Micheál Martin said it was a 'significant win' for the EU and highlighted the arrangements for the pharmaceutical and aviation sectors. Advertisement The statement said that as of September 1st, the US will apply a maximum tariff rate of 15 per cent on 'generic pharmaceuticals and their ingredients and chemical precursors'. Simon Harris, Tánaiste and Minister for Foreign Affairs and Trade, welcomed the clarity the statement offered on the EU-US trade agreement announced on July 27th. 'We welcome clarity that the deal includes a single, all-inclusive 15 per cent tariff on EU goods,' Mr Harris said. 'We also now have assurance that this rate will extend to pharmaceuticals and semiconductors. Advertisement 'This provides an important shield to Irish exporters that could have been subject to much larger tariffs pending the outcomes of Section 232 US investigations into these sectors.' There is also a 'zero-for-zero' tariff rate carve outs for aircraft and aircraft parts, with further carve outs to be determined for certain products in generic pharmaceuticals and chemicals. Mr Harris said this offered a 'first step' to a more 'comprehensive and formal agreement with the US in the future'. 'Our intention now is to see what other carve outs can be made in areas of interest for Irish exporters.' Advertisement Taoiseach Micheál Martin said the statement brought 'greater clarity and certainty' to what the agreement between the EU and the US will mean in practice. 'This is especially important for enterprises that either import from or export to the US. 'Given the scale of the pharmaceutical and semiconductor sectors in Ireland, it is important that the Joint Statement confirms that 15 per cent is a ceiling that will apply to EU exports in these areas in all circumstances, including when the current US Section 232 investigations are concluded. 'While I have been clear all along that I do not support tariffs, this is a significant win for the EU. Advertisement 'Given the significance of the airline sector to Ireland, a specific carve-out for aircraft and aircraft parts is also welcome. 'There are areas where further work remains to be done, including a potential carve-out for med-tech products and spirits. 'I hope this will be advanced as quickly as possible. We will continue to advocate for these sectors given their significant importance to our domestic economy.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store